Here is why Pfizer can't seem to get off the mat and whether it's worth buying the dip on today. I won't rehash Pfizer's pandemic journey too much. The company developed and sold a vaccine (Comirnaty) ...

Second, Pfizer's forward dividend yield stands at 7.47%. At first glance, the drugmaker's dividend payout ratio of 122.5% ...

Jim Cramer once confidently backed Pfizer, praising its pipeline and high dividend, forecasting a big post-COVID comeback. “I ...

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Markets expect ...

This big drugmaker has been a favorite for income investors for years. However, its dividend is arguably more attractive than ever. At this writing, the forward dividend yield stands at a ...

We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best ...

We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best ...

The company offers a quarterly dividend of $0.43 per share for a dividend yield of 7.72%, as of May 9. Overall, Pfizer Inc. (NYSE:PFE) ranks first on our list of the best high yield dividend stocks.

This steep decline, driven by waning COVID-19 product sales and tariff uncertainties, has sparked debate about whether PFE’s current valuation, bolstered by a 7.5% dividend yield and a forward P ...

With limited near-term catalysts to offset these pressures, Pfizer’s stock could face further selling pressure post-earnings. While its dividend yield remains attractive at current price levels, ...